These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16919723

  • 1. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
    Föger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A.
    Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
    [Abstract] [Full Text] [Related]

  • 2. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
    Föger F, Schmitz T, Bernkop-Schnürch A.
    Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
    [Abstract] [Full Text] [Related]

  • 3. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF, Hombach J, Bernkop-Schnürch A.
    Int J Pharm; 2008 Feb 04; 348(1-2):54-60. PubMed ID: 17716840
    [Abstract] [Full Text] [Related]

  • 4. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
    Iqbal J, Hombach J, Matuszczak B, Bernkop-Schnürch A.
    J Control Release; 2010 Oct 01; 147(1):62-9. PubMed ID: 20603165
    [Abstract] [Full Text] [Related]

  • 5. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J, Hoyer H, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2008 Jan 01; 33(1):1-8. PubMed ID: 17980561
    [Abstract] [Full Text] [Related]

  • 6. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
    Werle M, Hoffer M.
    J Control Release; 2006 Mar 10; 111(1-2):41-6. PubMed ID: 16377016
    [Abstract] [Full Text] [Related]

  • 7. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
    Iqbal J, Shahnaz G, Perera G, Hintzen F, Sarti F, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2012 Jan 10; 80(1):95-102. PubMed ID: 21964316
    [Abstract] [Full Text] [Related]

  • 8. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    J Control Release; 2004 Mar 24; 95(3):547-55. PubMed ID: 15023465
    [Abstract] [Full Text] [Related]

  • 9. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
    Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV, Elmquist WF.
    J Pharmacol Exp Ther; 2001 Feb 24; 296(2):551-7. PubMed ID: 11160643
    [Abstract] [Full Text] [Related]

  • 10. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
    Sakloetsakun D, Iqbal J, Millotti G, Vetter A, Bernkop-Schnürch A.
    Drug Dev Ind Pharm; 2011 Jun 24; 37(6):648-55. PubMed ID: 21561400
    [Abstract] [Full Text] [Related]

  • 11. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
    Kafedjiiski K, Hoffer M, Werle M, Bernkop-Schnürch A.
    Biomaterials; 2006 Jan 24; 27(1):127-35. PubMed ID: 16045983
    [Abstract] [Full Text] [Related]

  • 12. Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan.
    Föger F, Kafedjiiski K, Hoyer H, Loretz B, Bernkop-Schnürch A.
    J Drug Target; 2007 Feb 24; 15(2):132-9. PubMed ID: 17365284
    [Abstract] [Full Text] [Related]

  • 13. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine.
    Dorababu M, Nishimura A, Prabha T, Naruhashi K, Sugioka N, Takada K, Shibata N.
    Biomed Pharmacother; 2009 Nov 24; 63(9):697-702. PubMed ID: 19819100
    [Abstract] [Full Text] [Related]

  • 14. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
    Sharma P, Varma MV, Chawla HP, Panchagnula R.
    Farmaco; 2005 Nov 24; 60(11-12):874-83. PubMed ID: 16243320
    [Abstract] [Full Text] [Related]

  • 15. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.
    Shen Q, Lin Y, Handa T, Doi M, Sugie M, Wakayama K, Okada N, Fujita T, Yamamoto A.
    Int J Pharm; 2006 Apr 26; 313(1-2):49-56. PubMed ID: 16500056
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: in vitro and in vivo studies in rats.
    Hirunpanich V, Murakoso K, Sato H.
    Int J Pharm; 2008 Mar 03; 351(1-2):133-43. PubMed ID: 18082981
    [Abstract] [Full Text] [Related]

  • 17. Improved paracellular uptake by the combination of different types of permeation enhancers.
    Guggi D, Bernkop-Schnürch A.
    Int J Pharm; 2005 Jan 06; 288(1):141-50. PubMed ID: 15607266
    [Abstract] [Full Text] [Related]

  • 18. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM.
    J Pharm Pharm Sci; 2007 Jan 06; 10(3):319-31. PubMed ID: 17727795
    [Abstract] [Full Text] [Related]

  • 19. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.
    Johnson BM, Charman WN, Porter CJ.
    AAPS PharmSci; 2002 Jan 06; 4(4):E40. PubMed ID: 12646011
    [Abstract] [Full Text] [Related]

  • 20. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
    Zambito Y, Zaino C, Uccello-Barretta G, Balzano F, Di Colo G.
    Eur J Pharm Sci; 2008 Apr 23; 33(4-5):343-50. PubMed ID: 18296036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.